Investing in Pharma (Part 1) - Divi's Laboratories Being one of the biggest API manufacturers in the world, Divi's stock prices are quite expensive. In this episode, I breakdown the reasons as to why the company is trading at a PE of 71 while also giving an account of the risks the company faces and; eventually, attempting to decide if the stock prices are justified. Tune in to find out more about Divi's Labs.Read the full blog <a href="https://blog.sid.business/p/investing-in-pharma-part-1-divis" target="_blank">here</a>

Investing in Pharma (Part 1) - Divi's Laboratories Being one of the biggest API manufacturers in the world, Divi's stock prices are quite expensive. In this episode, I breakdown the reasons as to why the company is trading at a PE of 71 while also giving an account of the risks the company faces and; eventually, attempting to decide if the stock prices are justified. Tune in to find out more about Divi's Labs.Read the full blog here

Bazaar

Investing in Pharma (Part 1) - Divi's Laboratories

Understanding the economy, one scoop at a time.

About

Bazaar